Table 1.
Single Subject Timeline.
| DAY | Procedure |
|---|---|
| 1–21 | Titration to steady state medication levels. |
| 22 | Human laboratory session to model smoking lapse behavior (stress vs. neutral imagery, order counter-balanced). See Figure 1. |
| 24 | Human laboratory session to model smoking lapse behavior (stress vs. neutral imagery, order counter-balanced). See Figure 1. |
| 25 or 26 | fMRI session to evaluate attention and inhibitory control using Stroop task |
| 27 | Quit day |
| 34–53 | 1x weekly brief behavioral support during 4-week treatment period |
| 54–58 | Medication taper |
Note: Mean days between the two laboratory sessions = 2.24 days, SD=0.49; mean days from laboratory to fMRI session = 1.26 days, SD=0.47.